The global soft tissue sarcoma market represents a critical segment of the oncology therapeutics landscape, driven by rising cancer prevalence, advances in diagnostic technologies, and continuous innovation in treatment modalities. In 2024, the global soft tissue sarcoma market size was valued at USD 3,321.6 million. The market is projected to grow from USD 3,501.6 million in 2025 to USD...